![泌尿系疾病49張課件_第1頁](http://file4.renrendoc.com/view/719f08113e62b1e351a6168bfb52f202/719f08113e62b1e351a6168bfb52f2021.gif)
![泌尿系疾病49張課件_第2頁](http://file4.renrendoc.com/view/719f08113e62b1e351a6168bfb52f202/719f08113e62b1e351a6168bfb52f2022.gif)
![泌尿系疾病49張課件_第3頁](http://file4.renrendoc.com/view/719f08113e62b1e351a6168bfb52f202/719f08113e62b1e351a6168bfb52f2023.gif)
![泌尿系疾病49張課件_第4頁](http://file4.renrendoc.com/view/719f08113e62b1e351a6168bfb52f202/719f08113e62b1e351a6168bfb52f2024.gif)
![泌尿系疾病49張課件_第5頁](http://file4.renrendoc.com/view/719f08113e62b1e351a6168bfb52f202/719f08113e62b1e351a6168bfb52f2025.gif)
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
Theurinarysystem
Paediatricsof1sthospitalaffiliatedDalianmedicaluniversity
馬路一1TheurinarysystemPaediatrics22PhysiologicalfeaturesGlomerularfiltrationrate(GFR):
lowinneonateandinfantperiodUrineconcentrationanddilutionability
shortageRenaltubulefunction
insufficiency3PhysiologicalfeaturesGlomerulPhysiologicalFeaturesNormalurinaryoutput:
neonate:48h1~3ml/kg.h3~10d100~300ml/d2m250~400ml/d
~1y:400~500ml/d
~3y:500~600ml/d
~5y:600~700ml/d
~8y:600~1000ml/d
~14y:800~1400ml/d
>14y:1000~1600ml/d4PhysiologicalFeaturesNormaluPhysiologicalfeaturesurinaryoutput
neonateml/kg.hInfanttoddlerml/dPreschoolageml/dSchoolageml/doliguria<1.0<200<300<400urineless<0.5<505PhysiologicalfeaturesurinaryUrinalysisColor:colorlessorlightyellowpH:5~7Specificgravity:1.003~1.030(often1.011~1.025)Osmoticpressure:
infant:50~600mmol/L
children:
500~800mmol/LPhysiologicalfeatures6UrinalysisColor:colorlessorUrinalysisprotein:
negative:≤100mg/m2.24hprotein/creatinine≤0.2
positive:>150mg/d
or>4mg/m2.h
or>100mg/LUrinarycellandcast:
Urinarysediment:RBC<3/HP
WBC<5/HP
colorlesscastoccasionally
12hurineAddiscount:RBC<500000WBC<1000000cast<5000
PhysiologicalFeatures7Urinalysisprotein:PhysiologicaSerumanalysisThestandardindicatorsofrenalfunction
ureanitrogenandcreatinine
Theratio
:10:1.
Theratioincrease:
renalperfusion
or
urineflowisdecreased8SerumanalysisThestandardindSection2Classificationof
GlomerularDisease9Section2Classificationof
GClinicalClassification一、PrimaryGlomerularDisease
Glomerulonephritis
acutglomerulonephritis(AGN)
(Acutepoststreptococcalglomerulonephritis,APSGN)rapidlyprograssive(RPGN)
persistentchronic10ClinicalClassification一、PrimaClinicalClassificationniphroticsyndrome,NS
simpleTypeNSnephriticTypeNS
steroid-responsiveNSsteroid-resistantNSsteroid-dependentNSrelapsandfrequentlyrelaps11ClinicalClassificationniphrotClinicalClassificationIsolatedhemarutiaorproteinuria
Isolatedhematuria
persistentrecurrent
IsolatedProteinuria
orthostaticnon-orthostatic
12ClinicalClassificationIsolateClassificationClassification二、SecondaryglomerulardiseasespurpuranephritislupusnephritisHBV-associatedglomerulonephritisothers:poison,drug,viruset.al三、Hereditaryglomerulardiseasescongenitalnephroticsyndromehereditaryprogressivenephritisfamilialrecurrenthematuria13ClassificationClassificationSection3AcuteglomerulonephritisAG急性腎小球腎炎AcutepoststreptococcalglomerulonephritisAPSGN急性腎小球腎炎14Section3AcuteglomeruloneEtiologygroupAβ-heamolyticstreptococcalinfection.
upperrespiratorytractinfection51%skininfection25.8%acutepharyngtis,scarletfever1~5%othersbacteriaVirushelminth15EtiologygroupAβ-heamolyticsNephritisstrainassociatedprotein(Ag)
antigen-antibodycomplexesactivatethecomplementsystem
inciteglomemlarinflammationCap.endotheliumGMBGFR↓oliguriaNa,water↑edemahypertensionProteinuriahematuriacastMechanism16NephritisstrainassociatedprClinicalmanifestation
respiratorytractinfection
6~12dayspreviously
skininfection
14~28
dayspreviouslyrecenthistoryofgroupAβ-heamolyticstreptococcalinfection.17ClinicalmanifestationrespiraClinicalmanifestation
1.edema
70%,eyelidandface,
non-pitting;oliguria2.hematuria
50~70%,grosshematuriacoffee-colored
ortea-coloredurine
Typicform18Clinicalmanifestation1.edemClinicalmanifestation3.hypertension
30~80%,headachemaybepresent
4.Proteinuriadegreeisdifferent
pathology:
membranoproliferationTypicform19Clinicalmanifestation3.hyperClinicalmanifestationSeverehyperaemiaonthe
circulatorysystemHypertensiveencephalopathyAcuterenalfailure
severe
form20ClinicalmanifestationSeverehClinicalmanifestationAtypicformAsymptomsAGNOutofrenalsymptomsAGNAGNwhichissimilartonephroticsyndrom21ClinicalmanifestationAtypicf
hematuria:
+~+++
ESR:
↑↑
ASO:
10-14d
3-5w
peak
3-6m
normal
C3:
↓↓
6-8wnormal
protein:
+~+++Laboratoryevaluation
22hematuria:+~+++ESR:↑Diagnoses
previouslystreptococcaldisease
acuteonset
edema,
hematuria,
Proteinuria,
cast,
hypertension
ASO,C323DiagnosespreviouslystrepTreatmentRest:
keepthebed2~3W
Non-symptom:
Beoffthebed
ESRnormal:
gotoschool
Urinarysedimentcount:
normal,resumemovementGenerallytreatmentrest
24TreatmentRest:Generallytreatmdiet
Edemaandhypertension:Waterandsodiumsalt:belimited
sodiumsalt:
60mg/(kg.d)
water:
potentiallylosswatervolume
+urineoutput
serumlevelsofureanitrogenandcreatinine:proteinislimited
TreatmentGenerallytreatment25dietEdemaandTreatmentGen
Treatment
penicillineForinfectionifstillpresentPenicillin10~14dAntibiotictherapy
26
Treatment
penicillineForinfeTreatmentdiureticsantihypertensiveDihydrochlorothiazideFurosemideNifedipineCaptoprilReserpineSymptomatictreatment27TreatmentdiureticsantihypertenTreatmentSeverehyperaemia
HypertensiveencephalopathyAcuterenalfailurediuretics、antihypertensive、hemodialysisorperitonealdialysis
SodiumNitroprusside:thefirstchoices,SymptomatictreatmentSymptomatictreatmentaccordingtovariousmanifestation28TreatmentSeverehyperaemiaHypPrognosis
and
prevent
Theacuteabnormalitiesgenerallyresolvein2-3weeks;keypointofprevention:preventandcureinfection29Prognosis
and
Section4NephroticsyndromeNS
腎病綜合征30Section4NephroticsyndromeNIntrodution
Itisglomerulardisease,whichhascharacteristicclinicalandlaboratoryfindings,causebyvariousfactors.
Age:schoolage
male:female:3.7:1
31IntrodutionItisglomCharacteristic
proteinuriahypoproteinemia
(hypoalbuminemia)
hyperlipemiaandhyperlipoproteinemiaedema32Characteristicproteinuria32Classification1.primarynephroticsyndrome,PNS2.secondarynephroticsyndrome,SNS3.congenital
nephroticsyndrome,HNS33Classification1.primarynephroPathophysiology
Primaryrenalinjury
proteinuria
hypoproteinemiaedemahyperlipidemia
secondaryPathophysiologicalchange34PathophysiologyGlomemlarcapillaryvasselmoleculeandstaticbarrier-分子屏障靜電屏障分子屏障plasmproteinmoleculewithvariousdiameter
------------------35GlomemlarcapillaryvasselmolClinicalFinding
anddiagnosisAccordingtoClinicalFinding
1.simpletypeNS2.nephritictypeNS36ClinicalFinding
Clinicalmanifestation
anddiagnosis1.simpletypeNS
1)proteinuria:
urineprotein3+~4+
24hurineproteinquantitate≥50mg/kg
2)hypoproteinemia:
plasmalbumin<25g/L
3)hyperlipidemia:
plasmcholesterol
>5.7mmol/L
4)edema:
theseriouscase:anasarca,ascites,pleuraleffusions37Clinicalmanifestation
ClinicalFinding
anddiagnosis2.nephritictypeNS
Thereisoneormoreofitemsunderline:
①hematuria:
Urinarysediment:
3timeswithin2WRBC≥10/HP
②hypertension:
schoolage≥130/90mmHg,preschoolage≥120/80mmHg。
③renalfailure
④persistenthypocomplementemia
38ClinicalFinding
Complication1.infection
respiratorytractskinurethraperitonitis39Complication1.infection39Complication2.electrolytedisorderandintravascularvolumedepletion3.thrombosisandhypercoagulability
renalveinthrombusiscommon40Complication2.electrolytedisComplication
4.acuterenalfailure5.growthanddevelopisretarded41Complication4.acuterenalfTreatmentGenerally
1.rest2.diet:Waterandsodiumsaltarelimitedprotein:1.5~2g/kg·dCalciumandVitD;
3.diuretics:DihydrochlorothiazideFurosemide4.preventionandcureinfection42TreatmentGenerally42TreatmentCorticosteroidtreatment
:
Assoonasthediagnosisismade,corticosteroidtreatmentshouldbestarted.
Predinisone:2mg/kg.d(maximum,80mg/d),6W1.5mg/kg,singledose,qod,po,6Wthen,Gradually
reducethe
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年半包覆型鍍鋁玻璃纖維合作協(xié)議書
- 八年級(jí)英語下冊 Unit 6 單元綜合測試卷(人教河南版 2025年春)
- 2025年特種裝備電纜合作協(xié)議書
- 2025年主體結(jié)構(gòu)工程承包合同參考樣本(五篇)
- 2025年云南私營企業(yè)職工勞動(dòng)合同(2篇)
- 2025年中心幼兒園大班健康教學(xué)活動(dòng)總結(jié)(二篇)
- 2025年二建勞動(dòng)合同(三篇)
- 2025年企業(yè)個(gè)體銷售勞動(dòng)合同范文(2篇)
- 2025年臨時(shí)工聘用合同協(xié)議(三篇)
- 2025年個(gè)人租房簡易協(xié)議范文(2篇)
- 【可行性報(bào)告】2023年虛擬演播室制作設(shè)備相關(guān)行業(yè)可行性分析報(bào)告
- 世界老年人跌倒的預(yù)防和管理指南解讀及跌倒應(yīng)急處理-
- GB/T 7251.2-2023低壓成套開關(guān)設(shè)備和控制設(shè)備第2部分:成套電力開關(guān)和控制設(shè)備
- 第五講影響研究及研究方法(比較文學(xué)概論)課件
- 四川省地圖模板含市縣圖課件
- 帶拼音生字本模板(可A4打印)
- 小學(xué)語文必備文學(xué)常識(shí)常考100題匯總(含答案)
- 英語人教版高中必修三(2019新編)第一單元教案
- 超高大截面框架柱成型質(zhì)量控制
- GB 9706.1-2020醫(yī)用電氣設(shè)備第1部分:基本安全和基本性能的通用要求
- 森林法講解課件
評(píng)論
0/150
提交評(píng)論